CH593266A5 - - Google Patents

Info

Publication number
CH593266A5
CH593266A5 CH1140174A CH1140174A CH593266A5 CH 593266 A5 CH593266 A5 CH 593266A5 CH 1140174 A CH1140174 A CH 1140174A CH 1140174 A CH1140174 A CH 1140174A CH 593266 A5 CH593266 A5 CH 593266A5
Authority
CH
Switzerland
Application number
CH1140174A
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7333831A external-priority patent/FR2244459A1/fr
Priority claimed from FR7410327A external-priority patent/FR2265386A2/fr
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of CH593266A5 publication Critical patent/CH593266A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1140174A 1973-09-20 1974-08-21 CH593266A5 (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7333831A FR2244459A1 (en) 1973-09-20 1973-09-20 2-Arylamino-pyrimidines - useful as sedatives, antiinflammatory, anti-ulcer, vasodilating, anticholinergic and anti-broncho- constricting agents and diuretics
FR7410327A FR2265386A2 (en) 1974-03-26 1974-03-26 2-Arylamino-pyrimidines - useful as sedatives, antiinflammatory, anti-ulcer, vasodilating, anticholinergic and anti-broncho- constricting agents and diuretics

Publications (1)

Publication Number Publication Date
CH593266A5 true CH593266A5 (en:Method) 1977-11-30

Family

ID=26217948

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1140174A CH593266A5 (en:Method) 1973-09-20 1974-08-21

Country Status (12)

Country Link
US (1) US3978055A (en:Method)
JP (1) JPS5088079A (en:Method)
CA (1) CA1008074A (en:Method)
CH (1) CH593266A5 (en:Method)
DE (1) DE2444426A1 (en:Method)
ES (1) ES429869A1 (en:Method)
GB (1) GB1430729A (en:Method)
IT (1) IT1062796B (en:Method)
LU (1) LU70791A1 (en:Method)
NL (1) NL7412494A (en:Method)
SE (1) SE410600B (en:Method)
SU (1) SU645569A3 (en:Method)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1534593A (en) * 1976-09-03 1978-12-06 Soc D Etudes Prod Chimique N-2,6-dichlorophenyl-2-aminopyrimidine and therapeutic compositions containing it
JPS57203072A (en) * 1981-06-05 1982-12-13 Sankyo Co Ltd 4-anilinopyrimidine derivative, its preparation, antidepressant comprising it as active ingredient
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
US5254555A (en) * 1989-10-30 1993-10-19 Beecham Group P.L.C. Amino pyrimidin-7-yl substituted benzopyrans for treatment of hypertension
US7481790B2 (en) * 2000-12-27 2009-01-27 Advanced Cardiovascular Systems, Inc. Vessel enlargement by arteriogenic factor delivery
US20030055263A1 (en) * 2001-07-11 2003-03-20 Boehringer Ingelheim Pharma Kg Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production
DE10133665A1 (de) * 2001-07-11 2003-01-30 Boehringer Ingelheim Pharma Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
CA2517166A1 (en) * 2003-02-28 2004-09-16 Encysive Pharmaceuticals Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists
US7320989B2 (en) * 2003-02-28 2008-01-22 Encysive Pharmaceuticals, Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
US8455489B2 (en) 2003-11-10 2013-06-04 Exelixis, Inc. Substituted pyrimidine compositions and methods of use
BRPI0417354A (pt) * 2003-12-03 2007-03-13 Cytopia Res Pty Ltd compostos inibidores de tubulina, composições e seus usos
MY141255A (en) * 2003-12-11 2010-03-31 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
PT2922828T (pt) 2012-11-21 2020-10-12 Ptc Therapeutics Inc 4,6-diamino-pirimidina derivados como inibidores de bmi-1 para tratamento do cancro
WO2015030847A1 (en) 2013-08-30 2015-03-05 Ptc Therapeutics, Inc. Substituted pyrimidine bmi-1 inhibitors
EP3071553A4 (en) 2013-11-21 2017-08-02 PTC Therapeutics, Inc. Substituted pyridine and pyrazine bmi-1 inhibitors
CN104262263B (zh) * 2014-08-29 2017-01-11 西安交通大学 一种N,6二苯基嘧啶-4-胺类Bcr-Abl抑制剂及其制备方法和应用
CN113164479A (zh) 2018-08-17 2021-07-23 Ptc医疗公司 用于治疗胰腺癌的方法
EA202192117A1 (ru) * 2019-02-28 2021-11-23 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способ лечения множественной миеломы
MX2021011688A (es) * 2019-03-27 2022-01-24 Ptc Therapeutics Inc Combinaciones utiles en un metodo para tratar sarcoma.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321478A (en) * 1963-09-20 1967-05-23 American Cyanamid Co Aminoethoxyphenyl amine, ether, and sulfide derivatives of pyrimidine

Also Published As

Publication number Publication date
US3978055A (en) 1976-08-31
SE410600B (sv) 1979-10-22
IT1062796B (it) 1985-01-31
DE2444426A1 (de) 1975-03-27
SE7411806L (en:Method) 1975-03-21
AU7344174A (en) 1976-03-25
ES429869A1 (es) 1976-10-01
LU70791A1 (en:Method) 1975-06-11
JPS5088079A (en:Method) 1975-07-15
GB1430729A (en) 1976-04-07
CA1008074A (fr) 1977-04-05
NL7412494A (nl) 1975-03-24
SU645569A3 (ru) 1979-01-30

Similar Documents

Publication Publication Date Title
AR201758A1 (en:Method)
AU476761B2 (en:Method)
AU465372B2 (en:Method)
AR201235Q (en:Method)
AR201231Q (en:Method)
AU474593B2 (en:Method)
AU474511B2 (en:Method)
AU474838B2 (en:Method)
AU471343B2 (en:Method)
AU465453B2 (en:Method)
AU465434B2 (en:Method)
AU450229B2 (en:Method)
AU476714B2 (en:Method)
AR201229Q (en:Method)
AU476696B2 (en:Method)
AU472848B2 (en:Method)
AU466283B2 (en:Method)
AR199451A1 (en:Method)
AU477823B2 (en:Method)
AU477824B2 (en:Method)
AU476873B1 (en:Method)
AU447540B2 (en:Method)
AR193950A1 (en:Method)
AR195311A1 (en:Method)
AR195948A1 (en:Method)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased